BD Insulin Syringes with the BD Micro-Fine TM IV Needle recall: Sterility Concern
BD Insulin Syringes with the BD Micro-Fine TM IV Needle 1ml, 12.7mm, 28G Single Unit Scale. Insulin Syringes are designed for administering insulin in…
Why was BD Insulin Syringes with the BD Micro-Fine TM IV Needle recalled?
Nonsterile syringe potentially exposing the patient to pathogenic microorganisms and a risk of local infection.
What should I do if I have this product?
The recall is ongoing. Follow the firm and FDA instructions.
What to do with a recalled product: refunds, receipts, safe disposal and how to report a problem.
Is my product affected?
Compare the item in your hand with every identifier below from the official FDA record. Only products that match the listed product and lot, UPC or model codes are part of this recall.
Which lot codes, UPCs or models are affected?
GTIN: (01) 00382903294206 Lot Number: 2038204 Exp. Date: 20270430
- Product
- BD Insulin Syringes with the BD Micro-Fine TM IV Needle 1ml, 12.7mm, 28G Single Unit Scale. Insulin Syringes are designed for administering insulin in…
- Recalling firm
- Becton Dickinson & Company
- Quantity
- 961,000 units
- Distribution
- Worldwide distribution - US Nationwide and the countries of Chile, Colombia, Dominican Republic, Bahamas, Panama, Peru, Mexico, El Salvador, Mexico, Malaysia, Philippines, Vietnam, Hong Kong, Taiwan, Thailand, Canada.
- Recall date
- March 22, 2023
- Classification
- Class II
- Status
- Ongoing
- Agency
- FDA (device)